What are the side effects of Vyepti (eptinezumab)?

Commonly reported side effects of Vyepti (eptinezumab) include: anger, aura, brain fog, cluster headaches, complete lethargy, constipation, crying spells, depression worsening, dizziness, emotional numbness, fatigue, hallucinogenic effects, hemiplegic migraines, increased cold sensitivity, increased nausea, insomnia, lethargy, loneliness, loss of appetite, loss of motivation, mild nausea, nausea, neck pain, raynaud's phenomenon, restless sleep, sadness, suicidal ideation, swollen lymph nodes, temporary worsening the week after infusion, tiredness, visual migraine, worsened migraines, worsened symptoms. This treatment also carries an FDA black box warning.

How long does Vyepti (eptinezumab) take to work?

Vyepti (eptinezumab) typically shows results in 1 day, though individual responses vary.

Is Vyepti (eptinezumab) safe for long-term use?

Vyepti (eptinezumab) is generally not recommended for long-term use without medical supervision.

migraines Treatment Guide

Does Vyepti (eptinezumab) work for migraines?

Q: Does Vyepti (eptinezumab) work for migraines?

Research gives Vyepti (eptinezumab) a score of 72/100 for migraines (Moderate), based on 8 studies. Real user reports score it 75/100.

Vyepti (eptinezumab) has a research efficacy score of 72/100 for migraines — rated Moderate across 8 studies. Real users on social media rate it 75/100. It typically takes 1 day to show results.

Research

72 / 100

8 studies

Social

75 / 100

61 posts

Safety

57 / 100

See if Vyepti works for you — not just on average

Track daily, run your own experiment, get real data. Free.

Vyepti (eptinezumab) — treatment for migraines

How does Vyepti (eptinezumab) help migraines?

CGRP antagonism via monoclonal antibody binding

Category: monoclonal antibody

Efficacy: Research vs. Real Users

Research Evidence

72 / 100

Moderate

8 studies · 61 participants

Score derived from PubMed research published in the past year.

Real User Reports

75 / 100

Strong

61 posts

Self-reported results can be biased. Use as context, not proof.

How It Works

Administration Injection, Every 90 days
Time to work 1 day
Adult dose target Adults with episodic or chronic migraine who have failed at least 2 oral preventive treatments and benefit from rapid onset of action with quarterly intravenous dosing.

Safety Profile

⚠ FDA Black Box Warning

This treatment carries an FDA black box warning — the most serious type of safety alert. Consult your doctor before use.

/ 100

Safety Score: Moderate

Higher scores indicate a more favorable safety profile.

Known Side Effects

anger
aura
brain fog
cluster headaches
complete lethargy
constipation
crying spells
depression worsening
dizziness
emotional numbness
fatigue
hallucinogenic effects
hemiplegic migraines
increased cold sensitivity
increased nausea
insomnia
lethargy
loneliness
loss of appetite
loss of motivation
mild nausea
nausea
neck pain
raynaud's phenomenon
restless sleep
sadness
suicidal ideation
swollen lymph nodes
temporary worsening the week after infusion
tiredness
visual migraine
worsened migraines
worsened symptoms

Cautions

✓ Generally considered safe during pregnancy

⚠ Not recommended for long-term use without supervision

Who Should Consider Vyepti (eptinezumab)?

Severity Mild, moderate, severe
Minimum age 18 years old
Effective areas head
Category Non-steroid Prescription Medication

Lemma Health

Download the app — free.

Track your own Vyepti experiment and see whether it's actually helping — backed by your own data.

Frequently Asked Questions

Does Vyepti (eptinezumab) work for migraines?: Research gives Vyepti a score of 72/100 for migraines (Moderate), based on 8 studies. Real-user reports score it 75/100.
What are the side effects of Vyepti (eptinezumab)?: Commonly reported side effects include: anger, aura, brain fog, cluster headaches, complete lethargy, constipation, crying spells, depression worsening, dizziness, emotional numbness, fatigue, hallucinogenic effects, hemiplegic migraines, increased cold sensitivity, increased nausea, insomnia, lethargy, loneliness, loss of appetite, loss of motivation, mild nausea, nausea, neck pain, raynaud's phenomenon, restless sleep, sadness, suicidal ideation, swollen lymph nodes, temporary worsening the week after infusion, tiredness, visual migraine, worsened migraines, worsened symptoms. This treatment also carries an FDA black box warning.
How long does Vyepti (eptinezumab) take to work?: Vyepti typically shows results in 1 day, though individual responses vary. Tracking your symptoms with a structured experiment can help you know sooner.
Is Vyepti (eptinezumab) safe for long-term use?: Vyepti is generally not recommended for long-term use without medical supervision.
How do you use Vyepti (eptinezumab)?: Vyepti is administered injection, Every 90 days, at a target dose of Adults with episodic or chronic migraine who have failed at least 2 oral preventive treatments and benefit from rapid onset of action with quarterly intravenous dosing..
Is Vyepti (eptinezumab) safe during pregnancy or breastfeeding?: Vyepti is generally considered safe during pregnancy. Always confirm with your healthcare provider.

This page is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any treatment. Scores are derived from publicly available research and social media data and should not be used as a substitute for professional medical guidance.